Hassan EL BTAOURI

Prof. Hassan EL BTAOURI

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Chemotherapy Research and Practice
Verified
Journal Article
Open access
PDF file
GSGeorges Said
Georges Said
MGMarie Guilbert
Marie Guilbert
HMHamid Morjani
Hamid Morjani
RGRoselyne Garnotel
Roselyne Garnotel
PJPierre Jeannesson
Pierre Jeannesson
HBHassan EL BTAOURI
Hassan EL BTAOURI
Anticancer drug resistance is a multifactorial process that includes acquired andde novodrug resistances. Acquired resistance develops during treatment, whilede novoresistance is the primary way for tumor cells to escape chemotherapy. Tumor microenvironment has been recently shown to be one of the important factors contributing tode novoresistance and called environment-mediated drug resistance (EMDR). Two forms of EMDR have been described: soluble factor-mediated drug resistance (SFM-DR) and cell adhesion-mediated drug resistance (CAM-DR). Anthracyclines, among the most potent chemotherapeutic agents, are widely used in clinics against hematopoietic and solid tumors. Their main mechanism of action relies on the inhibition of topoisomerase I and/or II and the induction of apoptosis. Beyond this well-known antitumor activity, it has been recently demonstrated that anthracyclines may display potent anti-invasive effects when used at subtoxic concentrations. In this paper, we will describe two particular modes of EMDR by which microenvironment may influence tumor-cell response to one of these anthracyclines, doxorubicin. The first one considers the influence of type I collagen on the antimigratory effect of doxorubicin (CAM-DR). The second considers the protection of tumor cells by thrombospondin-I against doxorubicin-induced apoptosis (SFM-DR).

26 June 2020 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
THThinhinane Hocine
Thinhinane Hocine
SBSebastien Blaise
Sebastien Blaise
CHCathy Hachet
Cathy Hachet
AGAlexandre Guillot
Alexandre Guillot
HSHerve Sartelet
Herve Sartelet
HBHassan EL BTAOURI
Hassan EL BTAOURI

1 March 2002 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
Jorge Enrique Gomez-MarinJorge Enrique Gomez-Marin
Jorge Enrique Gomez-Marin
HBHassan EL BTAOURI
Hassan EL BTAOURI
ABAnnie Bonhomme
Annie Bonhomme
FAFrank Antonicelli
Frank Antonicelli
NPNathalie Pezzella
Nathalie Pezzella
JPJean M. Pinon
Jean M. Pinon

1 May 2011 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
HBHassan EL BTAOURI
Hassan EL BTAOURI
HMHamid Morjani
Hamid Morjani
YGYannick Greffe
Yannick Greffe
ECEmmanuelle Charpentier
Emmanuelle Charpentier
LMLaurent Martiny
Laurent Martiny

13 January 2006 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
HBHassan EL BTAOURI
Hassan EL BTAOURI
GRGeraldine Rath
Geraldine Rath
HMHamid Morjani
Hamid Morjani
CSChristophe Schneider
Christophe Schneider
EPEmmanuelle Petitfrere
Emmanuelle Petitfrere
LMLaurent Martiny
Laurent Martiny

19 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CLClaudia Herrera Leon
Claudia Herrera Leon
FRFrancisco Ramos-Martin
Francisco Ramos-Martin
HBHassan EL BTAOURI
Hassan EL BTAOURI
VAViviane Silva Pires Antonietti
Viviane Silva Pires Antonietti
Pascal SonnetPascal Sonnet
Pascal Sonnet
NDNicola D'Amelio
Nicola D'Amelio
Despite the remarkable similarity in amino acid composition, many anticancer peptides (ACPs) display significant differences in terms of activity. This strongly suggests that particular relative dispositions of amino acids (motifs) play a role in the interaction with their biological target, which is often the cell membrane. To better verify this hypothesis, we intentionally modify HB43, an ACP active against a wide variety of cancers. Sequence alignment of related ACPs by ADAPTABLE web server highlighted the conserved motifs that could be at the origin of the activity. In this study, we show that changing the order of amino acids in such motifs results in a significant loss of activity against colon and breast cancer cell lines. On the contrary, amino acid substitution in key motifs may reinforce or weaken the activity, even when the alteration does not perturb the amphipathicity of the helix formed by HB43 on liposomes mimicking their surface. NMR and MD simulations with different membrane models (micelles, bicelles, and vesicles) indicate that the activity reflects the insertion capability in cancer-mimicking serine-exposing membranes, supported by the insertion of N-terminal phenylalanine in the FAK motif and the anchoring to the carboxylate of phosphatidylserine by means of arginine side chains.